Advertisements

Roche drug cocktail doubles chance of holding lung cancer at bay

Roche drug cocktail doubles chance of holding lung cancer at bay.....»»

Category: topSource: business-standardDec 7th, 2017

Roche-AbbVie cancer drug gets accelerated FDA approval

Roche-AbbVie cancer drug gets accelerated FDA approval.....»»

Category: global-financeSource: reutersNov 21st, 2018

U.S. FDA panel backs Celltrion copycat of Roche blood cancer drug

U.S. FDA panel backs Celltrion copycat of Roche blood cancer drug.....»»

Category: global-financeSource: reutersOct 10th, 2018

Roche notches fresh win amid crowd of immunotherapy cocktails

Roche notches fresh win amid crowd of immunotherapy cocktails.....»»

Category: global-financeSource: reutersFeb 6th, 2018

AstraZeneca"s drug extending survival rate in lung cancer patients

AstraZeneca"s drug extending survival rate in lung cancer patients.....»»

Category: economySource: business-standardMay 26th, 2018

Cipla teams up with Roche Pharma to sell cancer therapy drugs in India

Cipla teams up with Roche Pharma to sell cancer therapy drugs in India.....»»

Category: featuresSource: business-standardFeb 28th, 2018

AstraZeneca#39;s immunotherapy drug wins key lung cancer approval

AstraZeneca#39;s immunotherapy drug wins key lung cancer approval.....»»

Category: topSource: moneycontrolFeb 19th, 2018

AstraZeneca"s immunotherapy drug wins key lung cancer approval

AstraZeneca"s immunotherapy drug wins key lung cancer approval.....»»

Category: global-financeSource: reutersFeb 19th, 2018

AstraZeneca"s immunotherapy drug gets US FDA nod for lung cancer treatment

AstraZeneca"s immunotherapy drug gets US FDA nod for lung cancer treatment.....»»

Category: global-financeSource: business-standardFeb 17th, 2018

Merck KGaA, Pfizer"s immunotherapy fails in lung cancer trial

Merck KGaA, Pfizer"s immunotherapy fails in lung cancer trial.....»»

Category: global-financeSource: reutersFeb 15th, 2018

US STOCKS-Industrials, techs lift Wall St, health stocks limit gains

US STOCKS-Industrials, techs lift Wall St, health stocks limit gains.....»»

Category: marketsSource: sifyNov 20th, 2017

US STOCKS-Tech stocks help Wall Street higher

US STOCKS-Tech stocks help Wall Street higher.....»»

Category: economySource: sifyNov 20th, 2017

Roche win boosts case for adding chemo to cancer immunotherapy

Roche win boosts case for adding chemo to cancer immunotherapy.....»»

Category: global-financeSource: business-standardNov 20th, 2017

Intas Pharmaceuticals Brings Down Cancer Treatment Cost by 60%

Intas Pharmaceuticals Brings Down Cancer Treatment Cost by 60%.....»»

Category: topSource: moneycontrolOct 5th, 2017

Novartis" skin cancer drug posts win in trials, Roche flops

Novartis" skin cancer drug posts win in trials, Roche flops.....»»

Category: global-financeSource: business-standardSep 11th, 2017

AstraZeneca rebuilds cancer drug hopes with new lung data

AstraZeneca rebuilds cancer drug hopes with new lung data.....»»

Category: global-financeSource: reutersSep 8th, 2017

Biocon drops after USFDA delays decision on biosimilar

Biocon drops after USFDA delays decision on biosimilar.....»»

Category: topSource: business-standardAug 31st, 2017

FDA Allows WIN Consortium to Proceed with Targeted Tri-Therapy Clinical Trial in First Line Treatment of Metastatic Non Small Cell Lung Cancer

FDA Allows WIN Consortium to Proceed with Targeted Tri-Therapy Clinical Trial in First Line Treatment of Metastatic Non Small Cell Lung Cancer.....»»

Category: press-releasesSource: businesswireindiaAug 9th, 2017

AstraZeneca Pharma gains 3% on plan to launch cancer drug in India

AstraZeneca Pharma gains 3% on plan to launch cancer drug in India.....»»

Category: topSource: moneycontrolJul 24th, 2017

Roche"s Tecentriq receives positive opinion from EU medicines agency

Roche"s Tecentriq receives positive opinion from EU medicines agency.....»»

Category: global-financeSource: reutersJul 22nd, 2017

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer

Vargatef┬« plus docetaxel could be an option after failure of immunotherapy in lung cancer.....»»

Category: press-releasesSource: businesswireindiaDec 15th, 2018